Fast-Track Loss In EU For Celgene’s CAR-T Cell Therapy

Liso-cel Review Will Take Longer Than Anticipated in EU As Well As In US

 
• By Maureen Kenny
  
Sand running through the bulbs of an hourglass measuring the passing time in a countdown to a deadline, on a dark background with copy space.
Time Is Not On Celgene's Side • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography